Vaxart, Immunovaccine, Mayo Clinic jump onto Zika vaccine bandwagon
Widening the field further, Vaxart, Immunovaccine and Mayo Clinic are joining a slew of biotechs and pharmas either exploring or embarking on Zika vaccine development.
U.K. rejects petition demanding meningitis B vaccine for all children
Sanofi's Dengvaxia is set for a wide rollout in the Philippines, making the endemic nation the first to implement an immunization campaign utilizing the dengue fever vaccine. Read more >>
Philippines' immunization program for Sanofi's Dengvaxia set to start in April
Sanofi's Dengvaxia is set for a wide rollout in the Philippines, making the endemic nation the first to implement an immunization campaign utilizing the dengue fever vaccine. Read more >>
TOP HEADLINES
Featured Story
Sanofi digs into details on hastened Zika effort
Just last month, Sanofi became the first Big Pharma player to enter the Zika vaccine R&D space as its peers calculated their responses and weighed their options. Now, the French pharma is taking it a step further, outlining its plans to devote dozens of scientists to the field in a move aimed at expediting its vaccine development.
Journal walks back 'seriously flawed' study critical of Merck's Gardasil
Citing "seriously flawed" methodology and "unjustified" claims, the journal Vaccine has permanently withdrawn a previously published study critical of Merck's Gardasil.
Duke, NIAID track HIV evolution with eyes on creating a vaccine
A team led by the Duke Human Vaccine Institute and the National Institute of Allergy and Infectious Diseases has tracked the evolution of HIV and the body's corresponding immune response, hoping now to turn the knowledge gained into an experimental vaccine.
South Korea's Green Cross to supply Americas with flu vaccine in $32M deal
South Korea's Green Cross announced a $32 million deal on Wednesday to supply its flu vaccines to the Pan American Health Organization, the WHO's regional office in the Americas.
Vaxart, Immunovaccine, Mayo Clinic jump onto Zika vaccine bandwagon
Widening the field further, Vaxart, Immunovaccine and Mayo Clinic are joining a slew of biotechs and pharmas either exploring or embarking on Zika vaccine development.
Sanofi digs into details on hastened Zika effort
Just last month, Sanofi became the first Big Pharma player to enter the Zika vaccine R&D space as its peers calculated their responses and weighed their options. Now, the French pharma is taking it a step further, outlining its plans to devote dozens of scientists to the field in a move aimed at expediting its vaccine development.
From Our Sister Sites
- FierceBiotech
- FierceBiotechIT
- FierceBiotechResearch
- FierceDrugDelivery
- FierceMedicalDevices
- FierceVaccines
- FiercePharma
- FiercePharmaAsia
- FiercePharmaManufacturing
- FierceCRO
- FierceDiagnostics
- FiercePharmaMarketing
- FierceAnimalHealth
- More Fierce Network sites
China FDA has said that generic drugs need to show bioequivalence to the related branded products, adding that the current use of locally-made generics will no longer suffice.
Activist investor and one-time Valeant enthusiast Bill Ackman is tired of waiting for Valeant's plunging stock price to turn itself around.
POPULAR COMMENT THREADS